Preoperative FOLFOXIRI Chemotherapy Combined With Lateral Lymph Node Dissection in Rectal Cancer
Ontology highlight
ABSTRACT: The goal of this clinical trial is to compare in newly diagnosed patients with resectable rectal cancer with lateral lymph node metastasis. This study aims to
* further verify the safety and efficacy of FOLFOXIRI three-drug regimen
* Using multiple omics techniques to identify and confirm specific molecular markers Participants will be treated with FOLFOXIRI three-drug combination regimen. Researchers will compare another group treated with conventional preoperative chemoradiotherapy to see if the experimental group is superior to the control group in terms of 3-year disease free survival, local recurrence rate, lateral lymph node positivity rate, and 5-year overall survival rate.
DISEASE(S): Neoplasm Metastasis,Rectal Neoplasms,Gastrointestinal Neoplasms,Oxaliplatin,Rectal Diseases,Lymph Node Metastasis,Lymphatic Metastasis,Cancer Of Rectum And Anus,Intestinal Neoplasms,Digestive System Neoplasms,Neoplasms
PROVIDER: 92794 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA